Latest Impairment News

Endeavour Group faces a leadership shake-up as Executive Chairman Ari Mervis resigns, with CFO Kate Beattie appointed interim CEO ahead of a strategic refresh and new chair search. The group also provides solid F25 sales and profit guidance despite restructuring costs.

Tourism Holdings Limited has dismissed a $2.30 per share acquisition offer from a BGH-led consortium, reaffirming its FY25 underlying profit expectations despite anticipating a statutory loss due to significant impairments.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.

Rapid Critical Metals has completed a $10.5 million capital raise to acquire major silver projects in New South Wales, appointed Byron Miles as Managing Director, and expanded its land holdings near the Webbs Silver Project by 26 times.

DGR Global Limited reports steady progress in project generation and subsidiary investments, bolstered by a $23.5 million loan facility and a favorable legal appeal outcome. The company maintains a strong health, safety, and environmental record while navigating challenging market conditions.

Australian Pacific Coal Limited has entered receivership over its Dartbrook Joint Venture assets following a senior secured debt default, casting doubt on the value of its 80% stake. Despite holding cash reserves, the company assumes no value in the joint venture amid ongoing financial distress.

Energy Resources of Australia Ltd narrowed its half-year loss to $35 million as it pressed ahead with the complex rehabilitation of the Ranger Project Area, backed by $1.24 billion in cash and investments. Meanwhile, Rio Tinto moves to compulsorily acquire remaining shares, signaling a new chapter for ERA’s future.

Beach Energy reported a 9% rise in FY25 production to 19.7 million barrels of oil equivalent and a 13% increase in sales revenue to $2 billion, driven by strong basin performances and the Waitsia LNG project. However, a significant $674 million impairment charge due to lower commodity prices and reserves revision at Beharra Springs tempers the upbeat results.

Syntara Limited reports encouraging Phase 2 data for its lead drug amsulostat in myelofibrosis, secures FDA Fast Track status, and expands clinical programs into myelodysplastic syndrome and keloid scars.

IGO Limited reported a robust operational quarter with improved safety and solid production at Greenbushes and Nova, offset by challenges at its Kwinana lithium refinery and an expected asset impairment.

IGO Limited reported robust operational performance in Q4 FY25 with improved safety and higher production at Greenbushes and Nova, while facing significant impairment at its Kwinana lithium refinery.

Mineral Resources Limited has met its FY25 production and cost guidance across all segments, boosted by a cashflow-positive Onslow Iron joint venture and record low costs at Wodgina. The company also strengthened its board and initiated a governance review.